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nvironmental inﬂuences have profound yet reversible
effects on the behavior of resident cells. Earlier data
have indicated that the amount of muscle formed from
implanted myogenic cells is greatly augmented by prior
irradiation (18 Gy) of the host mouse muscle. Here we
conﬁrm this phenomenon, showing that it varies between
host mouse strains. However, it is unclear whether it is due
to secretion of proliferative factors or reduction of anti-
proliferative agents. To investigate this further, we have
exploited the observation that the immortal myogenic C2
C12 cell line forms tumors far more rapidly in irradiated
 
than in nonirradiated host muscle. We show that the effect of
E
 
preirradiation on tumor formation is persistent and dose
dependent. However, C2 C12 cells are not irreversibly
 
compelled to form undifferentiated tumor cells by the irra-
diated muscle environment and are still capable of forming
large amounts of muscle when reimplanted into a nonirradi-
ated muscle. In a clonal analysis of this effect, we discovered
that C2 C12 cells have a bimodal propensity to form tumors;
some clones form no tumors even after extensive periods in
irradiated graft sites, whereas others rapidly form extensive
tumors. This illustrates the subtle interplay between the
phenotype of implanted cells and the factors in the muscle
environment.
 
Introduction
 
Developmental biology portrays a complex model of control
of cell movement and differentiation on the basis of cell
signaling mechanisms specified within a sequence of local
environments. But little is known about the equivalent
processes that maintain tissue integrity in the adult, where
it is particularly relevant to the accurate reconstruction and
regeneration that ensues after injury of most tissues. This
process involves coordinated activation, proliferation, migra-
tion, and differentiation of the component precursor cells
to form new tissue. Neoplasia represents uncontrolled
manifestation of one or more of these activities.
Skeletal muscle regeneration is a well-studied model that
superficially closely recapitulates embryonic myogenesis in
which activation, proliferation, and subsequent differentiation
of muscle precursor cells (MPC)* to form new muscle tissue
has been well described both in tissue culture and in vivo.
We have attempted to bridge the gap between in vivo and
in vitro models by transplantation of myoblasts, using the
immunodeficient, dystrophin-deficient mdx nu/nu mouse
host. A major goal in this work is to identify environmental
factors that optimize muscle formation from implanted cells.
Thus far, the most effective procedure is preirradiation of
host mouse muscle with 18 Gy. This causes the implanted
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cells to proliferate (Beauchamp et al., 1999), form more
muscle, and migrate to contiguous muscles more frequently
than in the nonirradiated leg (Morgan et al., 1993). The ir-
radiated muscle environment is thus clearly beneficial for
myoblast transplantation. However, the dose is too high to
be considered as a therapeutic option and we need, there-
fore, to understand its mechanism of action in the hope of
reproducing it by less extreme means.
To this end, we have established a simple assay for the effect
of preirradiation of the host muscle on implanted MPC, using
the myogenic cell line C2 C12 (Yaffe and Saxel, 1977; Blau et
al., 1983). These cells form muscle upon implantation into
mouse muscle, but eventually form tumors (Wernig et al.,
1991; Morgan et al., 1992). Such tumors formed far more
rapidly in irradiated than in nonirradiated mdx nu/nu mouse
muscles (Pagel et al., 2000), thus constituting a rapid and sen-
sitive assay for the growth promoting effects of irradiation.
Here, we have used C2 C12–derived tumor formation as a
measure of radiation-induced stimulation of muscle cell pro-
liferation, showing that this effect is persistent and that
switching of the C2 C12 cell phenotype from myogenic dif-
ferentiation to aggressive neoplastic behavior is reversible. We
have also identified individual retrovirally marked subclones
of C2 C12 cells that do or do not show this capacity for con-
version between neoplasia and differentiation.
 
Results
 
Implanted H2K 18 myoblasts form more muscle in 
irradiated muscles in some host strains
 
Significantly more muscle of donor origin was formed in irra-
diated mdx nu/nu and C5
 
 
 
/
 
 
 
 chain–deficient /Rag 2
 
 
 
 tibialis
anterior (TA) muscles than in contralateral, nonirradiated
muscles. This was true whether the number of dystrophin- or
Figure 1. Transverse cryostat sections of TA 
muscles that had been injected with H2K 18.30 
MPC 35 d earlier. (A) Muscle from the irradiated 
right leg of an mdx nu/nu mouse, stained with 
antidystrophin antibody and counterstained with 
haematoxylin to show the nuclei. A large group of 
dystrophin-positive fibers is shown. (B) Muscle 
from the contralateral, nonirradiated leg of an mdx 
nu/nu mouse, stained with antidystrophin antibody 
and counterstained with haematoxylin to show the 
nuclei. A few dystrophin-positive fibers are shown. 
(C) Serial section to A, stained for  -gal. A large 
group of donor fibers is present within this muscle. 
An asterisk marks the same fiber in sections A and 
C. (D) Serial section to B, stained for  -gal. Again, 
only a few donor fibers are found in the muscle. 
An asterisk marks the same fiber in sections B and 
D. (E) Muscle from the irradiated right leg of a 
beige/nu/Xid mouse, stained for  -gal. A small 
number of donor fibers are present only along the 
injection site. (F) Muscle from the nonirradiated 
left leg of a beige/nu/Xid mouse, stained for  -gal. 
As in E, a small number of donor fibers are present 
only along the injection site. (G) Muscle from the 
irradiated leg of a C5
 /  chain–deficient/Rag2
  
mouse, stained for  -gal. A large group of donor 
muscle fibers is present within this muscle. (H) 
Muscle from the nonirradiated left leg, contralateral 
to the muscle shown in G. Only a very few  -gal–
positive fibers are present. Bars, 100  m. 
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-gal–positive fibers or the amount of Y chromosome was
used as the measure of donor muscle in mdx nu/nu hosts (Fig.
1; Table I). However, mean activity of extracted 
 
 
 
-gal was not
significantly greater in homogenates prepared from irradiated
than nonirradiated mdx nu/nu muscles, indicating that this
may not be a reliable method for determining donor contribu-
tion to grafted muscle (Table I). Importantly, the number of
dystrophin- and 
 
 
 
-gal–positive fibers in representative sections
of mdx nu/nu muscles showed a 1:1 concurrence, the slope of
the number of 
 
 
 
-gal–positive fibers against the number of dys-
trophin-positive fibers was 1.01 (
 
r
 
2
 
 
 
 
 
 0.93; 
 
n
 
 
 
  
 
38), so we
could confidently use 
 
 
 
-gal immunostaining in nonmyopathic
hosts to quantify the amount of donor muscle formed.
However, when the same cells were implanted into non-
myopathic beige/nu/Xid mouse muscles, the amount of do-
nor muscle was not significantly greater in irradiated than in
nonirradiated muscles. (Fig. 1; Table I).
Our results show that radiation delivered to one leg does
not have a growth-promoting effect on cells implanted into
the contra-lateral leg. There was no significant difference in
the number of donor muscle fibers between the nonirradiated
muscles of mice that had their right leg irradiated (Table I, ex-
periments A2, E, and G) and mice of the same strain that had
neither leg irradiated (Table I, experiments B, F, and H).
 
Preirradiation of host muscle augments 
C2 C12–derived tumor formation
 
In both mdx and nonmyopathic immunodeficient host
strains, implantation of 5 
 
 
 
 10
 
5
 
 C2 C12 cells leads to the for-
mation of macroscopically visible tumors in all of the irradi-
ated muscles, but in none of the nonirradiated muscles (Fig.
2). Histologically, irradiated mdx nu/nu TA muscles that had
been injected with C2 C12 cells contained large numbers of
dystrophin-positive fibers, but also conspicuous areas of un-
differentiated interstitial cells, which we presume to be tumor
cells (Fig. 3 A). Similar undifferentiated cells were seen in irra-
diated, C2 C12 cell–injected beige/nu/Xid muscles (unpub-
lished data). Nonirradiated muscles contained smaller num-
bers of undifferentiated cells, interspersed diffusely between
donor muscle fibers (Fig. 3 B). In both host strains, signifi-
cantly more nondifferentiated interstitial cells were found in
the irradiated right TA than in the nonirradiated left TA (Ta-
ble II, experiments A1, A2, and F). Thus, 18 Gy of gamma ra-
diation, delivered to the host muscle 3 d before cell implanta-
tion, augments tumor formation from implanted C2 C12
cells in both myopathic and normal mouse muscles.
Similar effects were seen when nonmuscle cells were im-
planted into irradiated and nonirradiated mdx nu/nu TA
muscles, but these were less striking when nontransformed
Swiss 3T3 (donated by Professor Gullick, ICRF, London,
UK) rather than NIH 3T3 cells were used (unpublished
data), indicating that factors within irradiated muscle are
widely involved in cell proliferation.
 
Preirradiation of host skeletal muscle leads to a 
persistent enhancement of tumorogenesis
 
Visible tumors were found in all of the irradiated muscles
that had been injected with C2 C12 cells at all three time
points after irradiation (Table II, experiments A–C). They
 
Table I. 
 
Muscle formation from H2K 18.30 cells in irradiated and nonirradiated host muscles
Experiment Radiation dose Host mouse No. of mice Dystrophin-positive fibers
 
 
 
-Gal–positive fibers Male DNA
 
 
 
-Gal activity
 
A1 18 mdx nu 6 263.8 (57.0)
 
a
 
247.0 (55.8)
 
a
 
A1 0 mdx nu 6 78.7 (19.4) 80.5 (18.5)
A2 18 mdx nu 7 601.6 (116.4)
 
a
 
628.3 (119.7)
 
a,b
 
A2 0 mdx nu 7 209.6 (43.5) 173.1 (32.6)
B 0 mdx nu 6 196.0 (34.4) 173.3 (36.4)
C 18 mdx nu 6 249.8 (53.8)
 
a
 
C 0 mdx nu 6 71.3 (8.8)
D 18 mdx nu 7 1.02 (0.28)
D 0 mdx nu 7 0.3 (0.1)
E 18 Bnx 6 145.2 (33.2)
E 0 Bnx 6 104.5 (33.8)
F 0 Bnx 6 122.2 (21.7)
G1 8 C 5
 
 
 
6 188.3 (19.8)
 
a
 
G0 C 5
 
 
 
6 19.2 (11.9)
H0 C 5
 
 
 
4 99.4 (41.1)
Conditionally immortal H2K 18.30 MPCs were implanted into irradiated and nonirradiated TA muscles of mdx/nu/nu (mdx nu), beige/nu/Xid (Bnx), C5
 
 
 
/
gamma chain–deficient/Rag2
 
 
 
 (C5
 
 
 
) host mice. In three experiments (experiments B, F, and H), the values given are for both the left and right legs. The
amount of male DNA is given as ng/muscle. The amount of 
 
 
 
-gal activity is U/muscle. The radiation dose is given as grays (Gy). The values in the last four
columns are the mean with the SEM in parentheses.
 
a
 
Statistically significant difference (Mann-Whitney test) between values for the irradiated right TA and nonirradiated left TA.
 
b
 
Statistically significant difference between experiments 1 and 2 (Mann-Whitney test).
Figure 2. Mdx nu/nu mouse, whose right leg was irradiated with 
18 Gy 3 d before the injection of 5   10
5 C2 C12 cells into the 
right and left TA muscles. (A) 2 and (B) 6 wk after cell implantation. 
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were also seen in 2/7 of the nonirradiated muscles that were
contralateral to muscles irradiated 28 d before cell implanta-
tion. Histologically, significantly more interstitial cells were
found in the irradiated right TA muscles than in the nonir-
radiated, contralateral muscle at all three time points. Most
undifferentiated tissue was found when the cells were in-
jected 28 d after irradiation. However, noticeably less undif-
ferentiated tissue was found in muscles injected 100 d after
irradiation (Table II). This may reflect the loss of muscle
mass 100 d after irradiation, leaving fewer irradiated host fi-
bers than at earlier times to influence the implanted C2 C12
cells. Nonetheless, enhancement of C2 C12–derived tumor
formation clearly persists for at least 100 d after 18 Gy of ir-
radiation. Moreover, significantly more muscle fibers of do-
nor origin were also found in the muscles injected with C2
C12 cells at this time point than in the contralateral, nonir-
radiated legs (Table II).
 
C2 C12 tumorogenicity in vivo is dependent on the 
dose of preirradiation
 
Tumors were seen in 4/5 of the muscles irradiated with 9 Gy
and in only 4/11 of the muscles irradiated with 4.5 Gy (Table
II). The amount of nondifferentiated interstitial cells was far less
in the muscles preirradiated with either 9 Gy or 4.5 Gy than in
the muscles preirradiated with 18 Gy (Table II). These results
show that the radiation dose required to elicit rapid tumor for-
Figure 3. Transverse cryostat sections of TA 
muscles that had been injected with C2 C12 cells, 
stained for dystrophin, and counterstained with 
haematoxylin. (A) Mdx nu/nu TA muscle that had 
been irradiated with 18 Gy and then injected with 
C2 C12 cells 3 d later. (B) Muscle from the contralateral, 
nonirradiated leg. Arrows indicate undifferentiated 
cells; arrowheads indicate dystrophin-positive fibers. 
Bars, 100  m.
 
Table II.
 
 Muscle and tumor formation from C2 C12 cells, or C2 C12–derived tumor, in irradiated and nonirradiated host muscles
Experiment Radiation dose Host mouse
Interval between irradiation 
and transplant Tumor visible Undifferentiated tissue Dystrophin-positive fibers
 
A1 18 mdx nu 3 7/7 42.7 (5.3)
 
a
 
767 (256)
A1 0 mdx nu 3 0/7 8.9 (2.3) 331 (118)
A2 18 mdx nu 3 6/6 33.8 (5.0)
 
a
 
2820 (271)
 
a,b
 
A2 0 mdx nu 3 1/6 2.2 (0.71)
 
b
 
790 (193)
B 18 mdx nu 28 7/7 62.1 (4.4)
 
a
 
1189 (282)
B 0 mdx nu 28 2/7 7.6 (2.5) 679 (253)
C 18 mdx nu 100 7/7 22.1 (2.7)
 
a
 
1132 (108)
 
a
 
C 0 mdx nu 100 0/7 3.07 (0.95) 434 (346)
D 9 mdx nu 3 4/5 21.0 (6.2) 777 (281)
D 0 mdx nu 3 0/5 5.0 (1.8) 538 (255)
E1 4.5 mdx nu 3 3/6 3.6 (2.1) 148 (68)
 
a
 
E1 0 mdx nu 3 1/6 1.5 (0.73) 870 (251)
E2 4.5 mdx nu 3 1/5 8.5 (1.5)
 
a
 
1011 (182)
 
b
 
E2 0 mdx nu 3 0/5 0.99 (0.24) 624 (232)
F 18 Bnx 3 5/5 54.2 (3.8)
 
a
 
ND
F 0 Bnx 3 0/5 8.0 (1.4) ND
G 18 mdx nu 3 7/7 41.9 (6.9)
 
a
 
1761 (210)
 
a
 
G 0 mdx nu 3 0/7 12.5 (2.9) 552 (132)
H0
 
e
 
mdx nu 3 0/10 1.2 (0.16) 1261 (349)
C2 C12 cells, or C2 C12–derived tumor (experiment G), were implanted into irradiated and nonirradiated TA muscles of mdx nu/nu (mdx nu) and beige/nu/
Xid (Bnx) mice. In one experiment (experiment H), the results given are for both left and right legs. The radiation dose is given as grays (Gy). The values in
the column “tumor visible” are the number of legs that had macroscopically visible tumors out of the total number examined. The interval between irradiation
and transplant was measured in days. The undifferentiated tissue is presented as a percentage of the area. The values in the last two columns are the mean
with the SEM in parentheses.
 
a
 
Statistically significant difference (Mann-Whitney test) between values for the irradiated right TA and nonirradiated left TA.
 
b
 
Statistically significant difference between experiments 1 and 2 (Mann-Whitney test). 
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mation is critical; 18 Gy is effective, but 9 and 4.5 Gy are both
suboptimal to induce C2 C12 cells to rapidly form tumors.
Although there were variations in the amount of tumor
and extent of muscle formation between experiments, the re-
sults presented in Table II show no significant dose-depen-
dent change in the number of donor muscle fibers in irradi-
ated muscles. There does appear to be more donor muscle in
muscles irradiated with 18 Gy compared with contralateral
muscles, but this was not always significant. (Table II, exper-
iments A1 and A2).
The finding that the amount of donor muscle and undif-
ferentiated interstitial cells formed in nonirradiated muscles
varies from group to group (Table II) seems likely to be due
to interexperimental variation, rather than the irradiation of
one leg having a systemic or contralateral effect on the oppo-
site, nonirradiated leg. To confirm this, we injected C2 C12
cells from a single batch into both legs of mdx nu/nu hosts
that either had their right legs irradiated with 4.5 or 18 Gy
or had neither leg irradiated. We found no significant differ-
ence in the amount of donor muscle or the amount of non-
differentiated tissue in nonirradiated muscles, whether they
were from mice in which the right leg had been irradiated
with 4.5 or 18 Gy, or from mice which had neither leg irra-
diated (Table III, experiments A2, E2, and H).
 
C2 C12 tumors are capable of forming 
mature muscle upon serial transplant
 
To examine whether C2 C12–derived tumors are capable of
forming muscle in a second recipient host, C2 C12–derived
tumor tissue was transplanted from irradiated mdx nu/nu
host muscles into irradiated and nonirradiated legs of second
recipients, as described in the Materials and methods. 3 wk
later, tumors were apparent in the irradiated legs but not in
the nonirradiated legs (Table II, experiment G), with irradi-
ated TA muscles containing significantly more undifferenti-
ated interstitial cells than nonirradiated TAs. Moreover, it
was noticeable that, in addition to tumors in irradiated sites,
both irradiated and nonirradiated muscles contained large
numbers of dystrophin-positive donor muscle fibers (Fig. 4),
and the amount of donor muscle was significantly greater in
irradiated sites.
These results show that implantation of C2 C12–derived
tumors into a second series of irradiated or nonirradiated mdx
nu/nu mouse muscle leads to the formation of donor muscle,
recapitulating the original in vivo behavior of C2 C12 cells.
 
Subclones of C2 C12 cells form tumors
 
The ability of C2 C12 cells to form tumors and muscle in
vivo was further examined using subclones derived from a
population of C2 C12 cells retrovirally infected with a
marker gene and an antibiotic resistance gene. Clones of ret-
rovirally infected C2 C12 cells that were 
 
 
 
-gal positive and
gave rise to myotubes in vitro were isolated and either
pooled and analyzed as an oligoclonal population or ana-
lyzed as separate clones.
For the oligoclonal analysis, seven clones were coinjected
into the irradiated right legs and nonirradiated left legs of 11
mice. Muscles from six of these mice were removed for anal-
ysis 21 d after cell injection. No tumors were visible in any
of the injected muscles, and sections of these muscles con-
tained very few, if any, undifferentiated cells. The remaining
five mice were left until 90 d after grafting; only one of these
irradiated muscles contained a small, macroscopically visible
tumor. All muscles contained conspicious amounts of donor
muscle (Fig. 5, A and B).
A further four clones were injected separately into irradi-
ated and nonirradiated mdx nu/nu muscles. 3 wk after cell
implantation, all clones gave rise to muscle, significantly
more donor muscle fibers being found in irradiated than in
nonirradiated muscles (Table III; Fig. 5, E and F). None of
the clones gave rise to visible tumors in nonirradiated mus-
cles (Table III). Of the four clones examined, clones 2, 9,
and 10 gave rise to visible tumors in irradiated legs and
formed significantly more undifferentiated interstitial cells
in irradiated than in nonirradiated legs. Muscles injected
with clone 5 did not develop any visible tumors and con-
tained very little undifferentiated tissue in either irradiated
or nonirradiated muscles (Table III; Fig. 5, C and D).
These data show that some subclones of C2 C12 cells
form tumors and some do not, indicating a heterogeneity in
the original C2 C12 cell line in response to an irradiated
muscle environment.
Figure 4. Transverse cryosections of mdx 
nu/nu TA muscles implanted with C2 C12–
derived tumor, stained for dystrophin, and 
counterstained with haematoxylin. (A) TA 
muscle that had been irradiated with 18 Gy 
and had C2 C12–derived tumor implanted 
3 d after irradiation. (B) Muscle from the non-
irradiated leg contralateral to A. Irradiated 
muscles in this experiment contained more 
donor muscle fibers than muscles that had been 
injected with cultured C2 C12 cells (Table II), 
although the fibers were very small in size 
(compare Fig. 4 with Fig. 3). Bars, 100  m. 
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Candidate myoblast proliferation or migration 
factors are not augmented in mouse 
skeletal muscle by radiation
 
To investigate whether factors that have been implicated in
the proliferation or migration of MPCs were altered in irra-
diated skeletal muscle (Bischoff, 1997; El Fahime et al.,
2000; Kastner et al., 2000),we examined the expression of
four growth factors (
 
 
 
-fibroblast growth factor [FGF], FGF-4,
FGF-6, and hepatocyte growth factor) and two matrix
metalloproteinases (MMP-2 and MMP-9) in mdx and C57
Bl/10 muscles 3 d after 18 Gy of irradiation. There were no
significant differences in expression of these proteins in irra-
diated and nonirradiated mdx and C57Bl/10 muscles (Fig.
6). Although the amounts of 
 
 
 
-FGF, FGF-4, and FGF-6
were slightly reduced in irradiated C57Bl/10 muscles and
slightly elevated in irradiated mdx muscles, these differences
were not significant. MMP-2 was slightly elevated in irradi-
ated C57Bl/10 muscles and slightly reduced in irradiated
mdx muscles, but there was no change in MMP-9 expres-
sion in irradiated muscles.
Figure 5. Transverse cryosections of irradiated 
mdx nu/nu TA muscles injected with C2 C12 cell 
clones expressing cytoplasmic-localizing LacZ
21 d earlier. (A) Muscle that had been injected 
with a mixture of seven clones, stained for
dystrophin. (B) Serial section to A, stained for
 -gal. (C) Muscle that had been injected with 
clone 2, stained for dystrophin. (D) Serial section
to C, stained for  -gal. An asterisk identifies the 
same fiber in C and D. (E) Muscle that had been 
injected with clone 5, stained for dystrophin. (F) 
Serial section to E, stained for  -gal. An asterisk 
identifies the same fiber in E and F. Bars, 100  m.
 
Table III. 
 
Tumor and muscle formation from C2 C12 subclones in irradiated and nonirradiated mdx nu/nu muscles
Experiment Radiation dose Clone implanted Tumor visible Undifferentiated tissue Dystrophin-positive fibers
 
 
 
-Gal–positive fibers
 
A 18 2 3/7 27.61 (3.54)
 
a
 
727.0 (290.6)
 
a
 
806.3 (329.8)
 
a
 
A 0 2 0/7   3.00 (1.44) 130.4 (36.7) 198.9 (61.7)
B 18 5 0/5 4.95 (1.6) 494.0 (100.8)
 
a
 
522.0 (103.3)
 
a
 
B 0 5 0/5 2.2 (0.51) 101.2 (42.3) 129.0 (52.8)
C 18 9 6/6 14.04 (1.6)
 
a
 
1184.7 (225.6)
 
a
 
1344.2 (263.0)
 
a
 
C 0 9 0/6 2.46 (1.2) 354.5 (109.3) 378.2 (117.5)
D 18 10 2/8 7.06 (1.49)
 
a
 
954.4 (162.7)
 
a
 
990.8 (187.5)
 
a
 
D 0 10 0/8 1.12 (0.27) 213.6 (55.4) 285.9 (70.7)
C2 C12 subclones were implanted into irradiated and nonirradiated TA muscles of mdx nu/nu host mice. The radiation dose is given as grays (Gy). Values
given for “tumor visible” are the number of legs that had macroscopically visible tumors out of the total number examined. The undifferentiated tissue is
presented as a percentage of the area. The values in the last three columns are the mean with the SEM in parentheses.
 
a
 
Statistically significant difference (Mann-Whitney test) between values for the irradiated right TA and nonirradiated left TA. 
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Discussion
 
Although radiation is often used therapeutically and as an
experimental tool, its effect on living tissues is poorly under-
stood. Here, we describe profound effects of a high dose of
radiation on the interaction between irradiated recipient tis-
sue and a population of nonirradiated cells subsequently
grafted into that tissue. We find a significant augmentation
of muscle formed from implanted conditionally immortal
MPCs in both myopathic mdx nu/nu and normal C5
 
 
 
/
 
 
 
chain–deficient/Rag2
  mouse muscles that had been preir-
radiated with 18 Gy. A similar trend was found in the beige/
nu/Xid mouse, but the difference was not statistically signif-
icant. Although the underlying mechanism responsible for
this is not understood, in this mouse, it may be due to a lack
of muscle response to the stimulus of irradiation.
The immortal C2 C12 myogenic cell line forms skeletal
muscle in greater amounts than do conditionally immortal
H2K18.30 MPCs, but also gives rise to tumors after several
weeks in vivo (Wernig et al., 1991; Morgan et al., 1992; Pa-
gel et al., 2000). Previous experiments have shown that
expansion of engrafted C2 C12 cells in muscle is not
constrained by normal myoblasts (Morgan et al., 1992),
implying that the irradiation-induced proliferation is not
simply a response to the creation of a vacant niche by abla-
tion of endogenous satellite cells. Formation of C2 C12–
derived neoplasms was considerably accelerated by preirradi-
ation of the graft site. C2 C12 cells invariably gave rise to
visible tumors within 3 wk in irradiated legs, but rarely in
the nonirradiated, contralateral legs. This is reflected in the
histology of the graft sites, which contained significantly
larger undifferentiated interstitial cell areas in irradiated than
in nonirradiated muscles in both mdx nu/nu and beige/nu/
Xid hosts. The tumor-enhancing effect of radiation persists
for at least 100 d and is dose dependent.
Our data imply that the effect of irradiation on enhance-
ment of cell proliferation is restricted to the site of irradia-
tion, for there is no systemic or contralateral effect, as has
been observed, for instance, in increased proliferation of
proximal tubule cells in mouse kidneys contralateral to an ir-
radiated kidney (Otsuka and Meistrich, 1993).
The mechanism by which irradiated tissue influences the
proliferation of grafted cells is not clear. Ionizing radiation
causes DNA damage, which, if not effectively repaired,
causes cell death after the first or second postirradiation mi-
tosis. Therefore, rapidly dividing cells, such as satellite cells
in growing skeletal muscle, are more sensitive to irradiation
than nondividing cells. Apart from preventing growth and
regeneration of dystrophic muscle (Wakeford et al., 1991;
Weller et al., 1991; Quinlan et al., 1995, 1997; Heslop et
al., 2000), the effects of high doses of radiation delivered to
mainly postmitotic skeletal muscle have scarcely been docu-
mented. Some increase in muscle fiber permeability in vitro
has been reported (Canaday et al., 1994), but does not seem
to occur in vivo (Pagel and Partridge, 1999). It has also been
reported that the structural proteins titin and nebulin are de-
graded immediately after irradiation (Horowits et al., 1986)
and that microvascular networks within skeletal muscle are
damaged by 10 Gy, causing a reduction of blood supply to
the muscle 30 d later (Roth et al., 1999).
It is quite possible that radiation induces either muscle or
nonmuscle cells within the graft site to produce growth fac-
tors that enhance donor cell proliferation. Indeed, radiation
has been reported to raise levels of growth factors in various
cells or tissues for up to 6 wk after irradiation (Peter et al.,
1993; Yi et al., 1996; Gorski et al., 1999; Kruse et al., 1999;
Mori et al., 2000; Wang et al., 2000). A survey of substances
that may affect growth or migration of MPCs detected no el-
evation of  -FGF, FGF-4, FGF-6, MMP-2, MMP-9, or
scatter factor (hepatocyte growth factor) in irradiated mus-
cles. However, the crucial determinant may be the availability
or efficiency of presentation, rather than the actual amount,
of growth factor. This explanation is consonant with the
long-lasting effect of irradiation, because a persistent change
in the composition of proteoglycans in the interstitium of
muscle might affect the presentation of growth factors by
connective tissue elements and augment muscle cell prolifera-
tion (Desgranges et al., 1999; Stockholm et al., 1999).
Alternatively, radiation might ablate an inhibitory agent.
Skeletal muscle is rarely the site of tumor formation (Hundt
et al., 1999), and it contains a substance(s) that inhibits tu-
mor proliferation (Bar-Yehuda et al., 1999). The notion of
inhibitory control of cell proliferation is also in accordance
with the fact that the muscle satellite cells are deeply quies-
cent in normal, mature, undamaged muscle, but are capable
of rapid proliferation in response to injury. Moreover, sim-
ple removal from the muscle environment evokes extremely
rapid activation of satellite cells (Beauchamp et al., 2000).
Effects of irradiated cells on the proliferation of nonirradi-
ated cells in vivo have been noted previously. For example,
nonirradiated mouse tumor cells mixed with irradiated cells
and implanted subcutaneously into host mice grew more
rapidly than the nonirradiated cells alone (Revesz, 1956,
1958). Similarly, tumor formation from mouse mammary
epithelial cells was enhanced by irradiation (4 Gy) of the
host mouse mammary glands before cell implantation (Bar-
cellos-Hoff and Ravani, 2000), and survival, migration, and
proliferation of implanted O2-A progenitor cells were en-
Figure 6. Irradiation induces no significant changes in the 
expression of growth factors or MMPs in skeletal muscle. Wild-
type (C57Bl/10) and mdx skeletal muscle were irradiated (18Gy), 
and specific growth factor and MMP expression was evaluated 
by immunoblotting. Relative levels of expression for each protein 
were determined in comparison with  -actin as control (bottom). 
Lanes 1 and 3 are C57Bl/10 and mdx irradiated muscle, and 
lanes 2 and 4 are control C57Bl/10 and mdx nonirradiated muscle.700 The Journal of Cell Biology | Volume 157, Number 4, 2002
hanced by preirradiation (40 Gy) of the rat spinal cord graft
site (Franklin et al., 1996). The proliferative effects of irradi-
ation that we have shown here appear, from previous work
on conditionally immortal myoblasts, to be restricted to a
small subpopulation of cells that shows characteristics of
early precursors (Beauchamp et al., 1999), perhaps corre-
sponding to the “reserve” satellite cells described by Schultz
(1996). It remains to be determined whether the C2 C12
cells that respond to the preirradiated graft site fall into the
analogous nondifferentiating reserve cells that have been de-
scribed in this line (Yoshida et al., 1998) and characterized
by expression of CD34 (Beauchamp et al., 2000). In the
context of current interest in circulating multipotential stem
cells (Ferrari et al., 1998; Gussoni et al. 1999; Lagasse et al.,
2000; Krause et al., 2001; Orlic et al., 2001), such a specific
stimulatory effect may be important, because these cells have
not been observed, so far, to make more than a rare and triv-
ial contribution to myogenesis, even when directly injected
into the muscle.
To our surprise, the switch to tumor formation in C2 C12
cells implanted into an irradiated environment was not irre-
vocable, because fragments of C2 C12–derived tumor pro-
duced very large amounts of muscle in a second host. Curi-
ously, even in preirradiated sites in a second host, they
produced more muscle than had been present in the original
tumor, implying that they had been in some way altered by
this first exposure to an irradiated environment. Thus, C2
C12 cells behave in an analogous way to primary (Yao and
Kurachi, 1993) and conditionally immortal muscle cells
(Morgan et al., 1994; Gross and Morgan, 1999) in that they
function as MPCs after their implantation.
Our cloning experiments demonstrate that C2 C12 cells
comprise a bimodal population in their propensity to form
tumors in vivo. Initially, we implanted a mixture of retrovi-
rally marked clones into irradiated mdx nu/nu mouse mus-
cles and found a tumor in only one out of five muscles, ex-
amined 90 d later. This lack of tumorogenicity may have
been due to the insertion of the retrovirus or the expression
of  -gal, or again, exposure to geneticin rather than to the
clonal selection itself. Immune rejection of cells marked with
 -gal–expressing retroviruses (Abina et al., 1996; Visted et
al., 2000) is unlikely in our immunodeficient mice, where
we always find  -gal–expressing muscle fibers. Moreover,
upon analysis of single clones, we found one retrovirally in-
fected C2 C12 subclone that produced only muscle and gave
rise neither to tumors nor to the excess of interstitial cells
that are normally associated with grafts of C2 C12 cells.
Other subclones gave rise to both muscle and tumor in irra-
diated legs. Of practical interest, the clone that gave rise
to no undifferentiated tumor tissue provides an excellent
model of muscle regeneration. The existence of nontumor-
forming clones may explain the lack of tumors in previous
experiments where C2 cells had been transfected in vitro and
selected or cloned before their transplantation (Hamamori
et al., 1994, 1995; Dhawan et al., 1996; Bohl and Heard,
1997). We have yet to determine whether the tumor-form-
ing clone contains subclones that can still form muscle in a
second host mouse.
The interaction between a cell and its environment in
postnatal tissue is crucial to the fate of the cell. Environmen-
tal changes occur during differentiation, growth, and disease
processes and after external damage to the tissue. We have
shown that modulating the host environment by gamma ir-
radiation before cell implantation augments muscle forma-
tion from MPCs by driving them into proliferation. Simi-
larly, it drives proliferation of C2 C12 cells, but, additionally,
it generates an accelerated neoplastic transformation that is
reversible upon return of the cells to a nonirradiated environ-
ment. This demonstrates a profound phenotypic modulation
by purely environmental factors. It may be akin to the
changes from neoplastic behavior of teratoma cells and their
normal integration into developing embryos (Mintz and Ill-
mensee, 1975; Illmensee and Mintz, 1976) and the effect of
the environment on the transformation of a normal cell into
a malignant cell (for review see Park et al., 2000). Identifica-
tion of the factor(s) within irradiated muscle that effects the
proliferation of implanted cells would be important for the
development of new strategies both for preventing tumor
formation and improving myoblast transfer to treat myopa-
thies such as Duchenne muscular dystrophy.
Materials and methods
Cell culture
The first experiments were designed to measure the amount of donor muscle
formed in irradiated and nonirradiated host muscles. To standardize experi-
mental conditions, we used a clonal muscle cell line for our donor cells,
rather than primary MPCs, which show some variation between individual
preparations. We used a male, conditionally immortal clone, H2K 18, de-
rived from the H2K
b ts A58 transgenic mouse (Jat et al., 1991) that prolifer-
ates at 33 C in the presence of gamma interferon and forms normal muscle
(and not tumor) when implanted into mouse muscle (Morgan et al., 1994;
Beauchamp et al., 1999; Gross and Morgan, 1999). Cells were grown as de-
scribed previously (Morgan et al., 1994) and were infected with a retrovirus
coding for cytoplasmic-localizing LacZ (Adam et al., 1991; Fassati et al.,
1996) and recloned in geneticin (600  g/ml) to obtain a sub-clone that was
myogenic, nontransformed, and 100%  -gal positive (H2K 18.30).
To assay the growth promoting effects of irradiation, we used C2 C12
donor cells (Yaffe and Saxel, 1977; Blau et al., 1983). C2 C12 cells were
cultured in flasks, coated with 0.01% gelatin, in DME containing 10%
FCS. In some experiments, C2 C12 cells were infected with the retrovirus
coding for cytoplasmic LacZ and cloned in G418 to obtain clones that
were 100%  -gal positive.
The above cell lines were kept as replicate vials frozen in liquid nitro-
gen. For each experiment, a single vial was thawed and cultured for 3 or
4 d before implantation. Pellets containing 5   10
5 cells were prepared for
implantation.
Cell implantation
Dystrophin-deficient mdx mouse muscle undergoes extensive spontaneous
degeneration and regeneration accompanied by infiltration of cells such as
macrophages. To determine how the growth-promoting effect of irradia-
tion is occurring, it is important to establish whether radiation has a similar
effect on muscles that are not already undergoing these dynamic pro-
cesses. We therefore compared two strains of nonmyopathic, immunodefi-
cient mice to the mdx nu/nu host mouse as hosts for myoblast transplanta-
tion. The right legs of 3-wk-old mdx nu/nu (Partridge et al., 1989), beige/
nu/Xid (Zietman et al., 1991), or C5
 /  chain–deficient/Rag2
  (Goldman et
al., 1998; Mazurier et al., 1999; Cooper et al., 2001) mice were irradiated
with either 18, 9, or 4.5 Gy at a dose rate of 0.7 Gy/min (Gross et al.,
1999). Control host mice had neither leg irradiated. 3, 28, or 100 d after ir-
radiation, mice were anaesthetized either as before or with isofluorane,
and cell pellets were injected with a Hamilton syringe, via a small skin in-
cision, into the TA muscles of the left and right legs (Partridge et al., 1989).
For serial transplant of C2 C12–derived tumors, 5   10
5 C2 C12 cells
were implanted into TA muscles of two mdx nu/nu hosts that had been
preirradiated with 18 Gy. 3 wk later, the mice were killed and equal-sized
pieces of tumor were excised from the TA muscles. These were implanted
into a slit made in TA muscles of both legs of a fresh set of mdx nu/nu mice
whose right legs had been irradiated with 18 Gy 3 d earlier.Preirradiation of host muscle affects grafted cells | Morgan et al. 701
Analysis of muscles
In mdx host mice, dystrophin may be used as a marker for muscle of donor
origin. To enable us to identify muscle of donor origin in normal hosts, we
marked the donor cells with a retrovirus expressing cytoplasmic-localizing
LacZ. To validate this marker, we had to establish whether dystrophin and
 -gal expression concurred in mdx nu/nu host muscles that had been in-
jected with retrovirally marked donor cells.
Muscles injected with H2K 18.30 cells were removed for analysis 5 wk
after cell implantation. Muscles injected with C2 C12 cells were removed
for analysis 3 wk after cell implantation. This earlier time point was chosen
for the latter experiment because tumors had formed in the irradiated legs by
this time. Where myogenic cells had been injected into mdx hosts, the num-
ber of dystrophin-positive fibers in a representative cryostat section was
counted (Morgan et al., 1993). Where donor cells were expressing LacZ, the
number of fibers expressing LacZ was counted (Gross and Morgan, 1999).
The amount of tumor was calculated by estimating (from a random spot
sample) the percentage of a representative cross section that was occupied
by undifferentiated interstitial cells (Curtis, 1960).
To determine whether estimates of donor muscle achieved by counting
the number of donor muscle fibers in a representative cross section tallied
with measurements of the amount of donor DNA and  -gal activity present
in a sample of a homogenate of the entire muscle, TA muscles from six fe-
male mice that had been injected with H2K 18.30 cells were removed and
homogenized in 2 ml of DME. DNA was prepared from the entire muscle
and the amount of male DNA was quantified by slot blotting (Beauchamp
et al., 1999). In another experiment, TA muscles from seven female mice
that had been injected with H2K 18.30 cells were removed, homogenized
in DME, and an aliquot was taken for  -gal assay (Guerette et al., 1997).
Mean values were compared by the Mann-Whitney test.
Growth factor and MMP expression in irradiated and 
nonirradiated muscle
A number of candidate factors involved in myoblast proliferation and/or
migration were compared between irradiated and nonirradiated muscle by
Western blot analysis. Both legs of 3-wk-old mdx and wild-type C57Bl/10
mice were irradiated with 18 Gy. Nonirradiated littermate mdx and C57Bl/
10 mice were used as controls. 3 d after irradiation, muscles were re-
moved, snap frozen in liquid nitrogen, and prepared for SDS-PAGE and
Western blotting. In brief, muscles from four to five mice were pooled, ho-
mogenized in 650  l of 250 mM Tris HCl, 10 mM EDTA, pH 7.4, and frac-
tionated (2–10  g of protein per lane) on 4–12% Tris-glycine SDS-PAGE
gels (Invitrogen). Separated proteins were electroblotted onto Hybond C
 
extra nitrocellulose membranes (Amersham Pharmacia Biotech), and the
membranes were stained with Ponceau red (Sigma-Aldrich) before block-
ing by incubation in 5.0% nonfat milk in PBS. After blocking, antibodies
(1–5  g per ml) against the following proteins were used to detect expres-
sion: hepatocyte growth factor (Cambio);  -FGF, FGF-4, and FGF-6 (R&D
Systems); and MMP-2 and MMP-9 (Oncogene Research Products). Primary
antibodies were detected using biotinylated species-specific secondary an-
tibodies followed by the ABC system (Vector Laboratories). Protein compo-
nents were visualized using the ECL system (Amersham Pharmacia Bio-
tech) followed by exposure of the stained membrane to X-ray film
(Eastman Kodak Co.). Protein levels were determined by scanning densito-
metry using the Grab-it software (UVP). Values presented are representa-
tive of three experiments and the expression levels are given relative to
that of  -actin (Sigma-Aldrich) as loading control.
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